Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats

Journal of Neural Transmission

Volumn 106, Issue 3-4, 1999, Pages 229-242

  Ceresoli Borroni, G ^a   Guidetti, P ^a   Schwarcz, R ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Excitotoxicity; Glia; Huntington's disease; Kynurenines; Neurodegeneration

Indexed keywords

BRAIN ENZYME; KYNURENIC ACID; KYNURENINE; KYNURENINE AMINOTRANSFERASE; QUINOLINIC ACID;

ANIMAL MODEL; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; CORPUS STRIATUM; ENZYME ACTIVITY; HUNTINGTON CHOREA; MALE; NEOSTRIATUM; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; CORPUS STRIATUM; GLUTAMATE DECARBOXYLASE; INJECTIONS; ISOENZYMES; KINETICS; KYNURENIC ACID; LYASES; MALE; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TIME FACTORS; TRANSAMINASES;

EID: 0032917173     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050153     Document Type: Article

References (50)

1. Baran H, Gramer M, Hönack D, Löscher W (1995) Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats. Eur J Pharmacol 286: 167-175
2. Beal MF, Ferrante RJ, Swartz KJ, Kowall NW (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J Neurosci 11: 1649-1659
3. Beal MF, Matson WR, Storey E, Milbury P, Ryan EA, Ogawa T, Bird ED (1992) Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J Neurol Sci 108: 80-87
4. Björklund H, Olson L, Dahl D, Schwarcz R (1986) Short-and long-term consequences of intracranial injections of the excitotoxin quinolinic acid as evidenced by GFA immunohistochemistry of astrocytes. Brain Res 371: 267-277
5. Ceresoli G, Fuller MS, Schwarcz R (1996a) Excitotoxic lesions of the rat striatum: Different responses of kynurenine pathway enzymes during ontogeny. Dev Brain Res 92: 61-69
6. Ceresoli G, Guidetti P, Schwarcz R (1996b) Kynurenic acid production in the rat striatum: Acute and chronic effects of quinolinate lesions. Soc Neurosci Abstr 22:608-12
7. 3H]-kynurenine in the developing rat brain in vivo: Effect of intrastriatal ibotenate injections. Dev Brain Res 100: 73-81
8. Chase TN, Wexler NS, Barbeau A (1979) Advances in Neurology, Vol 23. Huntington's Disease. Raven Press, New York
9. Collingridge GL, Singer W (1990) Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 11: 290-296
10. Coyle JT, McGeer EG, McGeer PL, Schwarcz R (1978) Neostriatal injections: A model for Huntington's chorea. In: McGeer EG, Olney JW, McGeer PL (eds) Kainic acid as a tool in neurobiology. Raven Press, New York, pp 139-160
11. DiFiglia M (1990) Excitotoxic injury of thc neostriatum: A model for Huntington's disease. Trends Neurosci 13: 286-289
12. Eastman CL, Urbanska EM, Chapman AG, Schwarcz R (1994) Differential expression of the astrocytic enzymes 3-hydroxyanthranilic acid oxygenase, kynurenine aminotransferase and glutamine synthetase in seizure-prone and non-epileptic mice. Epilepsy Res 18: 185-194
13. Foster AC, Vezzani A, French ED, Schwarcz R (1984) Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci Lett 48: 273-278
14. Gramsbergen JBP, Hodgkins PS, Rassoulpour A, Turski WA, Guidetti P, Schwarcz R (1997) Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem 69: 290-298
15. 3H-kynurenine in the rat brain in vivo: Evidence for the existence of a functional kynurenine pathway. J Neurochem 65: 2621-2632
16. Guidetti P, Okuno E, Schwarcz R (1997) Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50: 457-465
17. Hamilton BF, Gould DH (1987) Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-nitropropionic acid toxicity in rats. Acta Neuropathol 74: 67-74
18. Heyes MP, Swartz KJ, Markey SP, Beal MF (1991) Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease. Neurosci Lett 122: 265-269
19. Hodgkins P, Schwarcz R (1998) Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: Reversal by lactate and pyruvate. Eur J Neurosci 10: 1986-1994
20. Holmes EW (1988) Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography. Anal Biochem 172: 518-525
21. Huntington's Disease Collaborative Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983
22. Isacson O, Fischer W, Wictorin K, Dawbarn D, Björklund A (1987) Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat. Neuroscience 20: 1043-1056
23. Jauch D, Urbanska E, Guidetti P, Bird ED, Vonsattel J-PG, Whetsell WO, Schwarcz R (1995) Dysfunction of brain kynurenic acid metabolism in Huntington's disease: Focus on kynurenine aminotransferases. J Neurol Sci 130: 39-47
24. König JFR, Klippel RA (1963) The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Williams & Wilkins, Baltimore
25. Kozlowski DA, Jones TA, Schallert T (1994) Pruning of dendrites and restoration of function after brain damage: Role of the NMDA receptor. Restor Neurol Neurosci 7: 119-126
26. Lees GJ (1993) Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 54: 287-322
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
28. Marty S, Dusart I, Peschanski M (1991) Glial changes following an excitotoxic lesion in the CNS.I.Microglia/macrophages. Neuroscience 45: 529-539
29. Moroni F, Russi P, Lombardi G, Beni M, Carlá V (1988) Presence of kynurenic acid in the mammalian brain. J Neurochem 51: 177-180
30. Okuno E, Nakamura M, Schwarcz R (1991) Two kynurenine aminotransferases in human brain. Brain Res 542: 307-312
31. Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg C, Baran L, Przegalinski E, Kostowski W, Krzascik P, Chizh B, Headley PM (1997) Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: Electrophysiological, biochemical and behavioral characterization. J Pharmacol Exp Ther 283: 1264-1275
32. Poeggeler B, Rassoulpour A, Guidetti P, Wu H-Q, Schwarcz R (1998) Dopaminergic control of kynurenate levels and NMDA toxicity in the developing rat striatum. Dev Neurosci 20: 146-153
33. Reynolds GP, Pearson SJ, Halket J, Sandler M (1988) Brain quinolinic acid in Huntington's disease. J Neurochem 50: 1959-1960
34. Roberts RC, Du F, McCarthy K, Okuno E, Schwarcz R (1992) Immunocytochemical localization of kynurenine aminotransfcrase in the rat striatum, A light and electron microscopic study. J Comp Neurol 326: 82-90
35. Saito K, Lackner A, Markey SP, Heyes MP (1991) Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increascd in type-D retrovirus infected macaques. Brain Res 540: 353-356
36. Schwarcz R, Coyle JT (1977) Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat. Life Sci 20: 431-436
37. Schwarcz R, Shoulson I (1987) Excitotoxins and Huntington's disease. In: Coyle JT (ed) Animal Models of Dementia: A Synaptic Neurochemical Perspective. Alan Liss, New York, pp 39-60
38. Schwarcz R, Whetsell WO, Jr, Mangano RM (1983) Quinolinic acid: An endogenous metabolite that causes axon-sparing lesions in rat brain. Science 219: 316-318
39. Schwarcz R, Tamminga CA, Kurlan R, Shoulson I (1988) Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia. Ann Neurol 24: 580-582
40. Schwarcz R, Du F, Schmidt W, Turski WA, Gramsbergen JBP, Okuno E, Roberts RC (1992) Kynurenic acid: A potential pathogen in brain disorders. In: Langston JW, Young A (eds) Neurotoxins and neurodegenerative disease. Ann NY Acad Sci 648: 140-153
41. Schwarcz R, Guidetti P, Roberts RC (1996) Quinolinic acid and kynurenic acid: Glia-derived modulators of excitotoxic brain injury. In: Aschner M, Kimelberg HK (eds) The Role of Glia in Neurotoxicity. CRC Press, Boca Raton, pp 245-262
42. Smith DE, Saji M, Joh TH, Reis D J, Pickel VM (1987) Ibotenic acid-induced lesions of striatal target and projection neurons: Ultrastructural manifestations in dopaminergic and non-dopaminergic neurons and in glia. Histol Histopathol 2: 251-263
43. +-independent transporter of neutral amino acids in astrocytes. J Neurosci 9: 2066-2072
44. Swartz KJ, Matson WR, MacGarvey U, Ryan EA, Beal MF (1990) Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection. Anal Biochem 185: 363-376
45. Turski WA, Schwarcz R (1988) On the disposition of intrahippocampally injected kynurenic acid in the rat. Exp Brain Res 71: 563-567
46. Turski WA, Nakamura M, Todd WP, Carpenter BK, Whetsell WO Jr, Schwarcz R (1988) Identification and quantification of kynuronic acid in human brain tissue. Brain Res 454: 164-169
47. Turski WA, Gramsbergen JBP, Traitler H, Schwarcz R (1989) Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J Neurochem 52: 1629-1636
48. Vacca LL, Nelson SR (1984) Glial cells in Huntington's chorea. Adv Cell Neurobiol 5: 221-250
49. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44: 559-577
50. Wu H-Q, Schwarcz R (1996) Seizure activity causes elevation of endogenous extracellular kynurenic acid in the rat brain. Brain Res Bull 39: 155-162